Maccura Biotechnology (300463.SZ) forecasts a decrease in annual net profit to be between 120 million yuan and 180 million yuan, a year-on-year decline of 42.42% to 61.61%.

Maccura Biotechnology (300463.SZ) disclosed the performance forecast for 2024, with the company expecting a net profit attributable to shareholders of the listed company of 120 million to 180 million yuan, a year-on-year decrease of 42.42% to 61.61%; the net profit after deducting non-recurring gains and losses is expected to be 118 million to 177 million yuan, a year-on-year decrease of 43.93% to 62.62%.